Prognostic significance of molecular remission in follicular lymphoma.
Dührsen
Ulrich
U
Hüttmann
Andreas
A
Dürig
Jan
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018572:Disease-Free Survival; D019008:Drug Resistance, Neoplasm; D015972:Gene Expression Regulation, Neoplastic; D050939:Gene Fusion; D050438:Genes, Immunoglobulin Heavy Chain; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality; D016133:Polymerase Chain Reaction; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000235:genetics*; D012008:Recurrence; D013997:Time Factors; D014178:Translocation, Genetic; D016896:Treatment Outcome
D019253:Proto-Oncogene Proteins c-bcl-2